Dr. Mark A. Tulli, MD

Dr. Tulli practices at The Cardiac & Vascular Institute in Gainesville, Florida.

Dr. Tulli's NPI, 1265484257, was assigned on May 17, 2006. Dr. Tulli graduated from Penn State College of Medicine in 1999. Dr. Tulli holds Florida license ME96062.

Dr. Tulli's primary practice is The Cardiac & Vascular Institute, at 4645 NW 8th Ave, Gainesville, FL 32605 in Alachua County. The practice phone is (352) 264-2500.

Dr. Tulli's primary practice is The Cardiac & Vascular Institute in Gainesville, Florida. Dr. Tulli is also affiliated with HCA Florida North Florida Hospital. The medical group on file is The Cardiac & Vascular Institute. Dmand AI also links Dr. Tulli to 1 more hospital and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tulli practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Tulli's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Tulli is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Tulli's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists angioplasty and cardiac catheterization among the conditions Dr. Tulli treats.

CMS data shows 5,985 Medicare services from Dr. Tulli across 46 procedure codes in 2024, for 1,503 Medicare patients. Medicare paid $604,003 for them.

CMS counts 1,503 Medicare patients who saw Dr. Tulli in 2024. The largest group is 75 to 84, with 692 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tulli's median patient age at 72, with 50% women.

In 2024, Dr. Tulli wrote 3,994 Medicare Part D claims for 689 patients. 72% of them were for generic drugs. CMS names the drug for 3,809 of them, across 44 drugs with 11 or more claims each, at $1,007,113 in total drug cost. In 2023, CMS named 3,270 claims across 40 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Tulli for performance year 2024, reported as part of a group. Dr. Tulli accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tulli as offering telehealth. CMS counts 60 procedures of coronary angioplasty and stenting by Dr. Tulli, more than 88% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Tulli in 2007. 2007 was the busiest year, with 2. The most frequent topics are Blood Flow Velocity, Coronary Circulation and Coronary Vessels. Dr. Tulli's most frequent co-authors are John D. Altman, MD, Jimmy Ray Baucum, MD and John P. Boehmer, MD.

Dmand AI links Dr. Tulli to 1 clinical trial. Conditions studied include Coronary Stenosis and Coronary Artery Disease.

CMS Open Payments shows 314 general payments to Dr. Tulli from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. Abbott Laboratories paid the most, $5,267.

Dmand AI lists 2 awards for Dr. Tulli, most recently CMS Stage 1 EHR in 2013.

Dr. Tulli graduated from Penn State College of Medicine in 1999. Dr. Tulli is a member of ACC.

Dr. Tulli is in network with 15 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.